Drug Shortage Report for TARO-MEROPENEM

Last updated on 2023-07-18 History
Report ID 175755
Drug Identification Number 02421518
Brand name TARO-MEROPENEM
Common or Proper name MEROPENEM
Company Name SUN PHARMA CANADA INC
Market Status MARKETED
Active Ingredient(s) MEROPENEM
Strength(s) 500MG
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS
Packaging size 10X1V
ATC code J01DH
ATC description OTHER BETA-LACTAM ANTIBACTERIALS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-05-01
Estimated end date 2023-07-16
Actual end date 2023-07-16
Shortage status Resolved
Updated date 2023-07-18
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 126 EAST DRIVE
BRAMPTON, ONTARIO
CANADA L6T 1C1
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2022-11-25 English Compare
v2 2022-11-25 French Compare
v3 2022-12-12 English Compare
v4 2022-12-12 French Compare
v5 2023-02-01 English Compare
v6 2023-02-01 French Compare
v7 2023-02-28 English Compare
v8 2023-02-28 French Compare
v9 2023-03-10 English Compare
v10 2023-03-10 French Compare
v11 2023-03-24 English Compare
v12 2023-03-24 French Compare
v13 2023-04-10 English Compare
v14 2023-04-10 French Compare
v15 2023-04-28 English Compare
v16 2023-04-28 French Compare
v17 2023-05-08 English Compare
v18 2023-05-08 French Compare
v19 2023-06-09 English Compare
v20 2023-06-09 French Compare

Showing 1 to 20 of 22